"AbbVie (ABBV) has been granted five US patents that specifically claim use of sofosbuvir and ledipasvir, the drug combination that Gilead (GILD) sells under the trade name Harvoni."
======================= I'm not saying that this will affect share price, market share, etc.
It is just an interesting and rather entertaining read.